RBC Capital analyst Michael Carroll raised the firm’s price target on American Healthcare REIT (AHR) to $45 from $39 and keeps an Outperform rating on the shares. The company delivered solid results highlighted by a stronger organic growth outlook and better investment pace, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Reports Strong Earnings Call
- American Healthcare REIT price target raised to $45 from $40 at Citizens JMP
- American Healthcare REIT Faces Risks from New Tax Legislation and Medicaid Cuts
- American Healthcare REIT Reports Strong Q2 2025 Results
- American Healthcare REIT’s New $1 Billion Equity Offering